Chanhold Evropska unija - slovenščina - EMA (European Medicines Agency)

chanhold

chanelle pharmaceuticals manufacturing ltd - selamektin - antiparazitni izdelki, insekticidi in repelenti - cats; dogs - mačke in psi:zdravljenje in preprečevanje bolh infestations zaradi ctenocephalides spp. en mesec po eni sami administraciji. to je posledica odraslih, larvicidnih in ovicidnih lastnosti proizvoda. proizvod je oviciden 3 tedne po uporabi. z zmanjšanjem števila bolh bolezen bo mesečno zdravljenje nosečih in doječih živali pripomoglo tudi k preprečevanju infestacij bolh v leglu do sedem tednov starosti. izdelek se lahko uporablja kot del strategije zdravljenja alergijskega dermatitisa z bolhami in s pomočjo ovacidnega in larvicidnega delovanja lahko pomaga pri nadzoru nad obstoječimi boleznimi bolh na območjih, na katerih ima žival dostop. preprečevanje bolezni srca, ki ga povzroča dirofilaria immitis z mesečnim dajanjem. izdelek lahko varno daje živali, ki so okužene s odraslih heartworms, vendar pa je priporočljivo, da v skladu z dobro veterinarsko prakso, da so vse živali, stari 6 mesecev ali več, ki živijo v državah, kjer je a vektor, ki obstaja, je treba preskusiti za obstoječe odraslih heartworm okužbe pred začetkom zdravil z izdelkom. priporočljivo je tudi, da psi morajo biti redno testirajo za odrasle heartworm okužb, kot sestavni del heartworm strategije preprečevanja, tudi če je bil izdelek dobivajo mesečno. ta izdelek ni učinkovit proti odraslih d. immitis. zdravljenje ušesnih pršic (otodectes cynotis). mačke:zdravljenje grize lice infestations (felicola subrostratus)zdravljenje odraslih roundworms (toxocara cati)zdravljenje odraslih črevesne hookworms (ancylostoma tubaeforme)zdravljenje grize lice infestations (trichodectes canis)zdravljenje sarcoptic mange (zaradi sarcoptes scabiei).

Tessie Evropska unija - slovenščina - EMA (European Medicines Agency)

tessie

orion corporation - tasipimidine sulfate - other hypnotics and sedatives - psi - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.

Bonqat Evropska unija - slovenščina - EMA (European Medicines Agency)

bonqat

orion corporation - pregabalin - antiepileptiki - mačke - alleviation of acute anxiety and fear associated with transportation and veterinary visits.

Imoxat Evropska unija - slovenščina - EMA (European Medicines Agency)

imoxat

chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). zdravilo za uporabo v veterinarski medicini se lahko uporablja kot del strategije zdravljenja alergijskega dermatitisa bolh (fad).  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). zdravilo za uporabo v veterinarski medicini se lahko uporablja kot del strategije zdravljenja alergijskega dermatitisa bolh (fad).

Filsuvez Evropska unija - slovenščina - EMA (European Medicines Agency)

filsuvez

amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - priprave za zdravljenje ran in razjed - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.

Melatonin Neurim Evropska unija - slovenščina - EMA (European Medicines Agency)

melatonin neurim

rad neurim pharmaceuticals eec sarl - melatonin - motnje v zvezi s spanjem in vzdrževanjem - psiholeptiki - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Abilify Maintena Evropska unija - slovenščina - EMA (European Medicines Agency)

abilify maintena

otsuka pharmaceutical netherlands b.v. - aripiprazol - shizofrenija - psiholeptiki - vzdrževalno zdravljenje shizofrenije pri odraslih bolnikih, stabiliziranih s peroralnim aripiprazolom.

Akynzeo Evropska unija - slovenščina - EMA (European Medicines Agency)

akynzeo

helsinn birex pharmaceuticals ltd - netupitant, palonosetron hidroklorid - vomiting; neoplasms; nausea; cancer - antiemetics in antinauseants, - akynzeo je navedeno v odraslim za:preprečevanje akutne in zapoznele slabost in bruhanja, povezanih z močno emetogenic cisplatin, ki temelji kemoterapijo raka. preprečevanje akutne in zapoznele slabost in bruhanja, povezanih z zmerno emetogenic kemoterapijo raka.

Atriance Evropska unija - slovenščina - EMA (European Medicines Agency)

atriance

sandoz pharmaceuticals d.d. - nelarabin - predkroglomerna limfoma t-celična limfoblastna levkemija - antineoplastična sredstva - nelarabine je indiciran za zdravljenje bolnikov z t-celic acute lymphoblastic levkemijo (t-all) in t-celic lymphoblastic limfom (t-lbl), katerih bolezen ni odgovorila, ali je relapsed po zdravljenju z vsaj dvema kemoterapijo regimens. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.

Emtricitabine/Tenofovir disoproxil Mylan Evropska unija - slovenščina - EMA (European Medicines Agency)

emtricitabine/tenofovir disoproxil mylan

mylan pharmaceuticals limited - emtricitabine, tenofovir disoproxil maleate - okužbe z virusom hiv - antivirusi za sistemsko uporabo - treatment of hiv-1 infection:emtricitabine/tenofovir disoproxil mylan is indicated in antiretroviral combination therapy for the treatment of hiv-1 infected adults (see section 5. emtricitabine/tenofovir disoproxil mylan is also indicated for the treatment of hiv-1 infected adolescents, with nrti resistance or toxicities precluding the use of first line agents, (see sections 4. 2, 4. 4 in 5. pre-exposure prophylaxis (prep):emtricitabine/tenofovir disoproxil mylan is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults and adolescents at high risk (see sections 4. 2, 4. 4 in 5.